- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03053791
Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait (DBS-SCI)
A Phase I/II Open-label Multicenter Trial to Evaluate Safety and Preliminary Efficacy of Unilateral Deep Brain Stimulation of the Mesencephalic Locomotor Region in Patients With Incomplete Spinal Cord Injury
Study Overview
Status
Conditions
Detailed Description
After approval by the local ethics committee we will perform a phase I open-label trial to evaluate safety and preliminary efficacy of unilateral deep brain stimulation of the mesencephalic locomotor region in patients with incomplete spinal cord injury. Male or female subjects (18-75 year-old) with completed in-patient rehabilitation will be enrolled for screening evaluations at minimum 3 months post-injury. DBS operation will be performed at minimum 3 months post-injury. Primary endpoint will be improvement of locomotion as determined by the 6-Minute walking test.
Secondary endpoints will be electrophysiological/clinical and image based characterization of the mesencephalic locomotor region, questionnaire based/ professional assessments of quality of life, pain, micturition, sleep behavior, cognitive function and psychiatric evaluations (mood, anxiety, impulse control, delusional and affective disorders). The study population will consist of 5 subjects and the study period for each patient is 6 months postoperatively. Briefly, candidate subjects, able to stand with a walker or 2 crutches and with stable neurological condition will have to meet all of the inclusion and none of the exclusion criteria. Subjects will have preoperative examinations (e.g. MRI scans of the head and spine, neuropsychological, psychiatric and sleep status etc.) according to our standard protocols of DBS for movement disorders, especially Parkinson's disease, based on certification criteria of Highly-Specialized-Medicine DBS centers in Switzerland. Neurological assessments for spinal cord injury impairment as defined by study protocol will be performed at the University Hospital Balgrist.
The operation will be performed in the Division of Neurosurgeon by the neurosurgical PI of this study: awake subjects will have their heads fixed in a stereotactic ring with local anesthesia and high resolution head scans will be performed to define the stereotactic space for targeting through anatomical landmarks defined on individual MRI as described in the literature. In contrast to bilateral implantations in Parkinsonian patients, here, a single burr hole will be opened under local anesthesia on the contralateral side of the worse lower extremity of the subject. Microelectrode recordings of single-cells as well as local field potentials will be mapped starting 1 cm prior the MLR target. Four states will be analyzed: resting state, imagination of walking, passive and active lower limb movement. These recordings will help to further determine the places of stimulation as the next step of surgery. Here, slow increases of the stimulation amplitude with a constant frequency of e.g. 50Hz will be applied to determine activation of lower limb muscle activity with electroneuromyographic recordings and detection of possible amelioration of intended active movements. Since the subject is awake, possible side effects will be professionally monitored at each site of stimulation and amplitude. Next, the electrode for recording and stimulation will be exchanged with the standard 8-contact directional DBS electrode for Parkinson's disease patients (1.28 mm in diameter, 1.5mm length of each contact and 0.5 mm spacing in between). All subjects will receive an intraoperative head scan to verify correct placement and accuracy. If refinement is not necessary, the first operative procedure will be regarded as finished and the subject will be transferred to the intermediate care unit overnight to recover from surgery. The surgeon will decide, if the impulse generator will be implanted in the same surgery or delayed. Subjects will undergo regular assessments until discharge and further on in an outpatient setup around day 30 post-surgery, as well as 3 and 6 months afterwards. Rehabilitative postoperative treatment will be assisted by using the recently CE certificated and award winning FLOAT system ("Free Levitation for Overground Active Training") which allows robotic multidirectional relief of body weight and exact gait/posture analysis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lennart H Stieglitz, MD
- Phone Number: 9905 +4144255
- Email: Lennart.Stieglitz@usz.ch
Study Contact Backup
- Name: Iris Krüsi
- Phone Number: 1111 +4144386
- Email: DBS-SCI@balgrist.ch
Study Locations
-
-
-
Zurich, Switzerland, 8008
- Recruiting
- Balgrist University Hospital
-
Contact:
- Iris Krüsi
- Phone Number: 1111 +4144386
- Email: DBS-SCI@balgrist.ch
-
Principal Investigator:
- Armin Curt, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informed Consent
- Participation in two assessment sessions before enrollment (Screening and baseline)
- Willingness and ability to comply with the protocol and to attend required study training and visits
- Male or female subjects
- Age 18-75
- Motor incomplete SCI
- Level of lesion: T10 and above, based on AIS level, preservation of sacral function
- Focal spinal cord disorder caused by either trauma or non-traumatic and non-progressive condition (like hemorrhage, benign tumor)
- Minimum 3 months of recovery after SCI
- Completed in-patient rehabilitation program
- WISCI II, level >2 (0-20 items): assistance of one or more persons. Ability to walk at least 10 meters
- Stable medical and physical condition.
- Adequate care-giver support and access to appropriate medical care in patient's home community
Exclusion Criteria:
- Enrollment of the investigator, his/her family members, employees and other dependent persons
- Limitation of standing and walking function based on accompanying (CNS) disorders
- Cardiovascular disorders restricting physical training or peripheral nerve disorders
- Implanted technical devices (pacemaker, defibrillator)
- History of significant autonomic dysreflexia
- Cognitive disorders/brain damage
- Drug refractory epilepsy
- Severe joint contractures disabling or restricting lower limb movements
- Haematological disorders with increased risk of bleeding during surgical interventions
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Congenital or acquired lower limb abnormalities (affection of joints and bone)
- Women who are pregnant or breast feeding or planning a pregnancy during the course of the study
- Lack of safe contraception
- Inability of the participant to follow the procedures of the study, e.g. due to language problems, psychological problems, dementia etc.
- Known or suspected non-compliance, drug or alcohol abuse
- Current or prior malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Single-armed study.
All patients will receive treatment.
|
Implantation of Electrodes in the Mesencephalic Locomotor Region for improvement of Locomotion and Gait
Implantation of a Medtronic Percept PC Impulse Generator for chronic Stimulation of the selected target.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in 6 Minute Walk Test at baseline and 6 months post intervention
Time Frame: preoperative, 6 months post intervention
|
Standardized test.
Patient is asked to walk for 6 minutes.
Result is the distance covered
|
preoperative, 6 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in 10 Meter Walking Test towards baseline
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Standardized test.
Patient is asked to walk 10 meters as quickly as possible.
Result is the speed (m/s)
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Change in Timed Up and Go test (TUG) towards baseline
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Standardized test.
Patient is asked to stand up from a sitting into Standing Position and walk 3 m and return to seated position.
Result ist time.
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Kinematic assessment during overground and treadmill walking
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Individuals are secured using the FLOAT.
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Change in Spinal cord Independence measure (SCIM III) towards baseline
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Standardized tool measuring the degree of independence of the subject.
Result is score.
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Change in Walking index for spinal cord injury (WISCI II) towards baseline
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Standardized tool measuring the subject's ability to walk.
Result is score.
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Long-term monitoring of physical activity
Time Frame: Continuously between discharge and 6 months follow-up
|
Wearable and wireless sensors are mounted to the patient and wheelchair for constant monitoring of physical activity
|
Continuously between discharge and 6 months follow-up
|
Electrophysiology
Time Frame: Baseline and several time-points throughout the study.
|
SSEPs, MEPs, DBS-EPs, LFPs, EMG
|
Baseline and several time-points throughout the study.
|
Changes in Electroencephalography towards baseline
Time Frame: preoperative, intraoperative, early postop, 6 months follow-up
|
Evaluation for the occuracne of EEG abnormalities
|
preoperative, intraoperative, early postop, 6 months follow-up
|
Change in Quality of life towards baseline
Time Frame: preoperative, 1,3,6 months follow-up
|
Standardized QOL tool (SF-36).
Result is score.
|
preoperative, 1,3,6 months follow-up
|
Change in lower urinary tract function towards baseline
Time Frame: preoperative, 6 months follow-up
|
Standardized tools QUALIVEEN, bladder diary, urodynamic assessments, renal and bladder ultrasound.
|
preoperative, 6 months follow-up
|
Change in sexual functions towards baseline
Time Frame: preoperative, 1,3,6 months follow-up
|
Use of the standardized tools FSFI (Female Sexual Function Index), result is score respectively IIEF (International Index of Erectile Function), result is score
|
preoperative, 1,3,6 months follow-up
|
Change in spasticity towards baseline
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Use of the standardized tool MAS (Modified Ashword Scale).
Result is score.
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Changes in ASIA impairment scale (AIS)
Time Frame: preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Assment of neurological status of individual with SCI
|
preoperative, early postop, before discharge, 1,3,6 months follow-up
|
Change in Upper limb Sensation, Strength and Prehension towards baseline
Time Frame: preoperative, 6 months follow-up
|
Standardized tool GRASSP
|
preoperative, 6 months follow-up
|
Change in sleepiness towards baseline
Time Frame: preoperative, 1,3,6 months follow-up
|
Standardized tool Epworth Sleepiness Scale
|
preoperative, 1,3,6 months follow-up
|
Change in Fatigue towards baseline
Time Frame: preoperative, 1,3,6 months follow-up
|
Standardized tool Fatigue Severity Scale
|
preoperative, 1,3,6 months follow-up
|
Change in pain sensation towards baseline
Time Frame: preoperative, 1,3,6 months follow-up
|
Standardized tools EPAF and SCIPI
|
preoperative, 1,3,6 months follow-up
|
Change in 6 Minute Walk Test at other timepoints towards baseline
Time Frame: Screening, early postop, before discharge, 1,3 months follow-up
|
Standardized test.
Patient is asked to walk for 6 minutes.
Result is the distance
|
Screening, early postop, before discharge, 1,3 months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lennart H Stieglitz, MD, University Hospital Zurich, Neurosurgery
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SNCTP000000598
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury
-
Taipei Veterans General Hospital, TaiwanThe Industrial Technology Research InstituteUnknownSpinal Cord Injuries | Complete Spinal Cord Injury | Incomplete Spinal Cord InjuryTaiwan
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingSCI - Spinal Cord Injury | Incomplete Spinal Cord InjuryUnited States
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
NervGen PharmaRecruitingSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
MetroHealth Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); Case Western...RecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury CervicalUnited States
-
Kevin KilgoreNational Institute of Neurological Disorders and Stroke (NINDS); Case Western... and other collaboratorsRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury Cervical | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
-
The University of Texas Health Science Center,...TerminatedSpinal Cord Injuries | Cervical Spinal Cord Injury | Traumatic Spinal Cord CompressionUnited States
-
StemCells, Inc.TerminatedStudy of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord InjuryCervical Spinal Cord Injury | Spine Injury | Cervical Spine InjuryUnited States, Canada
-
S.Biomedics Co., Ltd.Yonsei University; Linical Co., Ltd.RecruitingSpinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete LesionKorea, Republic of
-
Mahidol UniversityRecruitingSpinal Cord Injury | Incomplete Spinal Cord InjuryThailand
Clinical Trials on Deep brain stimulation in mesencephalic locomotor region
-
University of CopenhagenHvidovre University Hospital; Bispebjerg Hospital; Danish Parkinson AssociationCompletedParkinson's DiseaseDenmark
-
Abbott Medical DevicesTerminatedDepressive Disorder, Major | Unipolar DepressionUnited States, Canada, United Kingdom
-
Zhiqi MaoRecruitingParkinson's Disease | Executive Function | Electroencephalogram | Functional Near - Infrared SpectroscopyChina
-
Ali Rezai, MDCompleted
-
University Hospital Inselspital, BerneCompletedMovement Disorder | Urinary Tract DiseaseSwitzerland
-
University of MinnesotaRecruitingParkinson DiseaseUnited States
-
NewronikaTerminatedParkinson DiseaseItaly
-
Butler HospitalMedtronicCompletedObsessive-Compulsive DisorderUnited States
-
University of Sao Paulo General HospitalUnknownCerebellar AtaxiaBrazil
-
Qilu Hospital of Shandong UniversityRecruiting